STOCK TITAN

Syros to Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, March 27, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary
Syros Pharmaceuticals (SYRS) to report Q4 and full year 2023 financial results and host conference call on March 27, 2024.
Positive
  • None.
Negative
  • None.

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Syros Pharmaceuticals (NASDAQ:SYRS), a biopharmaceutical company committed to advancing new standards of care for the frontline treatment of hematologic malignancies, today announced that it will host a live conference call and webcast at 8:30 a.m. ET on Wednesday, March 27, 2024 to report its fourth quarter and full year 2023 financial results and provide a corporate update.

To access the live conference call, please dial (888) 259-6580 (domestic) or (416) 764-8624 (international) and refer to conference ID 21905455. A webcast of the call will also be available on the Investors & Media section of the Syros website at www.syros.com. An archived replay of the webcast will be available for approximately 30 days following the call.

About Syros Pharmaceuticals

Syros is committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies. Driven by the motivation to help patients with blood disorders that have largely eluded other targeted approaches, Syros is developing tamibarotene, an oral selective RARα agonist in frontline patients with higher-risk myelodysplastic syndrome and acute myeloid leukemia with RARA gene overexpression. For more information, visit www.syros.com and follow us on Twitter (@SyrosPharma) and LinkedIn.

Syros

Karen Hunady

Director of Corporate Communications & Investor Relations

1-857-327-7321

khunady@syros.com



Investors

Hannah Deresiewicz

Stern Investor Relations, Inc.

212-362-1200

hannah.deresiewicz@sternir.com

Source: Syros Pharmaceuticals

FAQ

When will Syros Pharmaceuticals report its Q4 and full year 2023 financial results?

Syros Pharmaceuticals will report its Q4 and full year 2023 financial results on March 27, 2024.

What time will the live conference call and webcast take place?

The live conference call and webcast will take place at 8:30 a.m. ET on March 27, 2024.

How can I access the live conference call?

To access the live conference call, dial (888) 259-6580 (domestic) or (416) 764-8624 (international) and refer to conference ID 21905455.

Where can I find the webcast of the call?

The webcast of the call will be available on the Investors & Media section of the Syros website at www.syros.com.

How long will the archived replay of the webcast be available?

The archived replay of the webcast will be available for approximately 30 days following the call.

Syros Pharmaceuticals, Inc.

NASDAQ:SYRS

SYRS Rankings

SYRS Latest News

SYRS Stock Data

5.54M
26.35M
0.74%
75.59%
8.33%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
CAMBRIDGE